Australian Clinical LabsACL 
$2.390.85%24h
0.85%24h
Global rank11622
Market cap$483.38M
Change 7d25.53%
YTD Performance22.92%
SP500 benchmarkOutperform
P/E0
P/S1.03
Revenue$468.23M
Earnings$24.38M
Dividend yield-
Main Sector
Healthcare
EPS for Australian Clinical Labs (ACL)
Australian Clinical Labs has an EPS of $0.8846. In 2021, the company made an earnings per share (EPS) of $0.3969. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for ACL
-
Value:-
EPS history for Australian Clinical Labs from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | $0.8846 | 122.88% |
| 2021 | $0.3969 | - |
View the highest EPS stocks
